Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
Children | Free Full-Text | Etiology and Epidemiology of Croup before and throughout the COVID-19 Pandemic, 2018–2022, South Korea
Singular Interface Dynamics of the SARS-CoV-2 Delta Variant Explained with Contact Perturbation Analysis | Journal of Chemical Information and Modeling
Vaccines | Free Full-Text | VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
Viruses | Free Full-Text | A Glimpse on the Evolution of RNA Viruses: Implications and Lessons from SARS-CoV-2
Multiplex Biosensing for Simultaneous Detection of Mutations in SARS-CoV-2 | ACS Omega
Vaccines | Free Full-Text | COVID-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo | Journal of Virology
File:São Crispim e S. Crispinianio.jpg - Wikimedia Commons
Viruses | Free Full-Text | Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
Viruses | Free Full-Text | A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil
Biomolecules | Free Full-Text | COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
How to get to S. Crispim in Porto by Bus, Metro or Train?
Atmosphere | Free Full-Text | Transmission of SARS-CoV-2 Indoor and Outdoor Environments
Biomolecules | Free Full-Text | Looking at COVID-19 from a Systems Biology Perspective
Microorganisms | Free Full-Text | SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants | Journal of Virology
Biomedicines | Free Full-Text | Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Vaccines | Free Full-Text | Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
Vaccines | Free Full-Text | Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination
Pharmaceuticals | Free Full-Text | Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo
Viruses | Free Full-Text | Emergence and Spread of a B.1.1.28-Derived P.6 Lineage with Q675H and Q677H Spike Mutations in Uruguay
Viruses | Free Full-Text | Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil
Viruses | Free Full-Text | Monitoring the Establishment of VOC Gamma in Minas Gerais, Brazil: A Retrospective Epidemiological and Genomic Surveillance Study
Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Microorganisms | Free Full-Text | SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
